LEADS BIOLABS-B (09887) announced on November 25, 2025, that its board has approved the proposal to adopt an H-share incentive plan. The H-share incentive plan aims to: promote the company's long-term sustainable development and performance goals; closely align the interests of recipients with those of shareholders, investors, and the company, thereby enhancing corporate cohesion and maximizing value; and improve the company's incentive mechanism to attract, motivate, and retain directors, senior management, and employees who contribute significantly to the group's ongoing operations, development, and long-term growth.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments